SCHEMBL3719145

SCHEMBL3719145

OCc1cccnc1-c1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.47
MAPK14 Q16539 3/20 0.44
BCHE P06276 1/20 0.43
PDK1 Q15118 1/20 0.40
CSNK1D P48730 2/20 0.40
CSNK1E P49674 1/20 0.40
KDM4E B2RXH2 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
LMNA P02545 2/20 0.40
MAPK10 P53779 1/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SQOR Q9Y6N5 1/20 0.39
KMT2A Q03164 2/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9030551 0.98 TRPV1 (0.46) TRPV1MAPK14BCHEPDK1CSNK1D
SCHEMBL26728878 0.85 BCHE (0.46) MAPK14BCHECSNK1DCSNK1EKDM4E
SCHEMBL3708397 0.84 MAPK14 (0.43) TRPV1MAPK14BCHEMAPK10KMT2A
SCHEMBL3711456 0.84 DPP4 (0.50) MAPK14BCHEMAPK10CYP1A2CYP2C19
SCHEMBL2889939 0.82 TRPV1 (0.47) TRPV1PDK1KDM4EL3MBTL1LMNA
SCHEMBL7160604 0.82 KDM4E (0.48) TRPV1PDK1KDM4EL3MBTL1LMNA
SCHEMBL30832971 0.82 KDM4E (0.48) TRPV1PDK1KDM4EL3MBTL1LMNA
SCHEMBL4049174 0.81 TRPV1 (0.47) TRPV1PDK1KDM4EL3MBTL1LMNA
SCHEMBL17455924 0.81 TRPV1 (0.46) TRPV1MAPK14PDK1CSNK1DKDM4E
SCHEMBL3907145 0.81 MAOB (0.44) TRPV1MAPK14BCHEMAPK10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010096722-A1 3-OXO-2, 3-DIHYDRO- [1,2, 4] TRIAZOLO [4, 3-A]PYRIDINES AS SOLUBLE EPOXIDE HYDROLASE (SEH) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-26 WO claimed
WO-2010096722-A1 3-OXO-2, 3-DIHYDRO- [1,2, 4] TRIAZOLO [4, 3-A]PYRIDINES AS SOLUBLE EPOXIDE HYDROLASE (SEH) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-26 WO disclosed
WO-2001096283-A9 HIV INTEGRASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2002-10-17 WO disclosed
EP-0727421-A1 Agents for improving sleep JANSSEN PHARMACEUTICA N.V. (BE) 1996-08-21 EP disclosed
US-5026853-A Sleep and cardiovascular disorders JANSSEN PHARMACEUTICA N.V. (BE) 1991-06-25 US disclosed
US-4880808-A SEDATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1989-11-14 US disclosed
EP-0285219-A2 Method of improving sleep JANSSEN PHARMACEUTICA N.V. (BE) 1988-10-05 EP disclosed